Industry slams B vitamins trial
A clinical trial that concluded B vitamins do not reduce the risk of cardiovascular (CV) events or death among patients with coronary heart disease has been criticised by industry for being poorly designed.
A clinical trial that concluded B vitamins do not reduce the risk of cardiovascular (CV) events or death among patients with coronary heart disease has been criticised by industry for being poorly designed.
A company focusing on how food could contribute to the treatment and prevention of obesity and “other chronic diseases” is the latest organization to throw its weight behind an innovation network which claims to help companies increase speed to market.
Good intentions when it comes to a healthy food go out of the window if people are stressed or hungry, increasing demand for products that offer instant gratification, according to a new study from the US Department of Agriculture's Economic Research...
Monsanto has found a buyer for its bovine somatotropin growth hormone, despite growing concern in the US over the use of such products in dairy cattle, as manufacturers continue to face commodity price uncertainty.
A decade of structural changes have helped Danisco position itself as “first choice” for customers, suppliers, business partners and employers, its chairman has said.
Swedish probiotics specialist BioGaia this morning announced a deal with Nestlé Nutrition that will see its proprietary Lactobacillus reuteri strain employed in infant nutrition products globally.
Condition-specific products make up almost one-third of all US nutritional supplement sales, led by joint health and calcium, according to a new market report.